- Patient/Guest
- Phlebotomist
- Updates
| Mean Corpuscular Hemoglobin Test |
|---|
| Measures MCH to diagnose anemia, causing fatigue or pale skin | ||
| Synonym | MCH Test | |
| Test Code | CHEM250052 | |
| Test Type | Hematology | |
| Pre-Test Condition | No special | |
| Report Availability | 1–2 D(s) | |
| # Test(s) | 1 | |
| Test details | Sample Report |
|---|---|
| Mean Corpuscular Hemoglobin Test |
|
| Synonym | MCH Test | ||
| Test Code | CHEM250052 | ||
| Test Category | |||
| Pre-Test Condition | No special | ||
| Medical History | Share & see Updates | ||
| Report Availability | 1–2 D(s) | ||
| Specimen/Sample | Refer Updates | ||
| Stability @21-26 deg. C | 24 H(s) | ||
| Stability @ 2-8 deg. C | 48 H(s) | ||
| Stability @ Frozen | Not frozen | ||
| # Test(s) | 1 | ||
| Processing Method | Biochemistry | ||
|
Overview: Mean Corpuscular Hemoglobin Test
Introduction: The Mean Corpuscular Hemoglobin Test measures MCH to diagnose anemia, causing fatigue or pale skin. Following 2023 ASH guidelines, it uses biochemical methods for high specificity, supporting hematological screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in hematology for patients with suspected anemia, such as iron deficiency or thalassemia. Other Names: MCH Assay, Hemoglobin Content Test. FDA Status: Laboratory-developed test (LDT), meeting hematology standards for diagnostic accuracy. Historical Milestone: MCH testing began in the 1960s with hematology research. Automated analyzers improved in the 2000s, enhancing diagnostic precision. Purpose: Measures MCH to diagnose anemia, guides treatment, and evaluates patients with fatigue or pale skin. Test Parameters: 1. Mean Corpuscular Hemoglobin Pretest Condition: No fasting required. Collect whole blood. Report history of fatigue, pale skin, or anemia symptoms. Specimen: Whole Blood (EDTA, 2-5 mL). Transport in a biohazard container. Sample Stability at Room Temperature: 24 hours Sample Stability at Refrigeration: 48 hours Sample Stability at Frozen: Not frozen Medical History: Document fatigue, pale skin, shortness of breath, or family history of anemia. Include current medications, especially iron supplements. Consent: Written consent required, detailing the tests purpose, anemia implications, and risks of blood collection. Procedural Considerations: Uses biochemical methods (e.g., automated hematology analyzer) to measure MCH in whole blood. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for anemia diagnosis. Factors Affecting Result Accuracy: Hemolysis, improper sample storage, or low sample volume can affect results. Analyzer calibration errors may reduce accuracy. Clinical Significance: Abnormal MCH suggests anemia (e.g., microcytic or normocytic), guiding treatment (e.g., iron therapy). Normal levels may require further hematological testing. Specialist Consultation: Consult a hematologist for result interpretation and treatment planning. Additional Supporting Tests: CBC, ferritin, or hemoglobin electrophoresis to confirm anemia diagnosis. Test Limitations: Not specific to one anemia type; clinical correlation is needed. Sample quality affects accuracy. References: ASH Anemia Guidelines, 2023; Blood, Kassebaum NJ, 2022. |
